Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Link

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Leukemia|July 1, 1997
Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemiaK W Maloney, J E Rubnitz, M L Cleary, et al.
Blood|July 15, 1994
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group studyJ E Rubnitz, M P Link, J J Shuster, et al.
Medical and Pediatric Oncology|February 1, 1995
Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group studyM B Harris, A B Cantor, A M Goorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Prognostic factors in childhood acute myelogenous leukemiaH E Grier, R D Gelber, B M Camitta, et al.
Blood|June 15, 1993
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalitiesS P Hunger, D C Tkachuk, M D Amylon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology surveyJ M Hilden, E J Emanuel, D L Fairclough, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
Cancer|July 1, 1989
Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research HospitalR E Hutchison, S B Murphy, D L Fairclough, et al.
Blood|February 1, 1988
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34S D Smith, R Morgan, R Gemmell, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Leukemia|July 1, 1997
Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemiaK W Maloney, J E Rubnitz, M L Cleary, et al.
Blood|July 15, 1994
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group studyJ E Rubnitz, M P Link, J J Shuster, et al.
Medical and Pediatric Oncology|February 1, 1995
Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group studyM B Harris, A B Cantor, A M Goorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Prognostic factors in childhood acute myelogenous leukemiaH E Grier, R D Gelber, B M Camitta, et al.
Blood|June 15, 1993
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalitiesS P Hunger, D C Tkachuk, M D Amylon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology surveyJ M Hilden, E J Emanuel, D L Fairclough, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
Cancer|July 1, 1989
Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research HospitalR E Hutchison, S B Murphy, D L Fairclough, et al.
Blood|February 1, 1988
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34S D Smith, R Morgan, R Gemmell, et al.
Pageof 11